Logo

Ingenuity Licenses Pathway Analysis Software to NCI

Apr 12, 2005

NEW YORK, April 12 (GenomeWeb News) - The National Cancer Institute Center for Cancer Research has licensed pathway analysis software from Ingenuity systems, the Mountain View, Calif.-based company said today.

 

Under the agreement, all researchers at the NCI will have access to Ingenuity's Pathway Analysis software, which includes a curated database of protein, gene, cell, tissue, drug, and disease networks.

 

Ingenuity aims to gain a stronger foothold in the academic and government research world this year, CEO Jake Leschly said in a company statement.

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.